AIG
FULC icon

American International Group’s Fulcrum Therapeutics FULC Stock Holding History

American International Group’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-24,899
Closed -$71K – 3110
2023
Q1 		$71K Buy
24,899
+4,301
+21% +$38.5K ﹤0.01% 2608
2022
Q4 		$150K Buy
20,598
+4,386
+27% +$28.6K ﹤0.01% 2304
2022
Q3 		$131K Buy
16,212
+229
+1% +$1.64K ﹤0.01% 2399
2022
Q2 		$78K Buy
15,983
+2,338
+17% +$22.8K ﹤0.01% 2718
2022
Q1 		$323K Sell
13,645
-961
-7% -$13.6K ﹤0.01% 1971
2021
Q4 		$258K Buy
14,606
+23
+0.2% +$456 ﹤0.01% 2213
2021
Q3 		$411K Buy
14,583
+2,172
+18% +$41.2K ﹤0.01% 1990
2021
Q2 		$130 Buy
12,411
+2,485
+25% +$25.1K ﹤0.01% 2766
2021
Q1 		$117 Buy
9,926
+1,607
+19% +$19.9K ﹤0.01% 2636
2020
Q4 		$97 Sell
8,319
-238
-3% -$2.69K ﹤0.01% 2677
2020
Q3 		$68K Buy
8,557
+907
+12% +$10.9K ﹤0.01% 2736
2020
Q2 		$140K Buy
7,650
+169
+2% +$2.66K ﹤0.01% 2319
2020
Q1 		$89K Buy
7,481
+4,638
+163% +$74.2K ﹤0.01% 2378
2019
Q4 		$47K Sell
2,843
-24
-0.8% -$229 ﹤0.01% 2896
2019
Q3 		$19K Buy
+2,867
New +$31.7K ﹤0.01% 3026

Other funds holding FULC

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

American International Group's FULC Position: Q2 2023 in Review

American International Group sold out of Fulcrum Therapeutics (FULC) in Q2 2023, closing a stake of 24,899 shares — an estimated $71K sold.

American International Group first reported a position in FULC in Q3 2019 and held it in 15 quarters. The position peaked at $411K in Q3 2021. 88 funds tracked by Wall St. Rank hold FULC as of Q2 2023.

  • American International Group reported no remaining Fulcrum Therapeutics position as of Q2 2023 after selling out during the quarter.
  • American International Group sold 24,899 Fulcrum Therapeutics shares in Q2 2023, an estimated $71K.
  • American International Group first reported a position in Fulcrum Therapeutics in Q3 2019 and held it in 15 quarters.
  • American International Group's Fulcrum Therapeutics position peaked at $411K in Q3 2021.
  • 88 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q2 2023.

Based on American International Group's 13F filing for Q2 2023, filed 4 Aug 2023.